Canaccord analyst William Plovanic raised the firm’s price target on DexCom (DXCM) to $103 from $99 and keeps a Buy rating on the shares. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback